هفته نامه اطلاع رسانی اختراعات منتشر شده در سازمان جهانی مالکیت فکری
		invbazaar.com

سال	هفته	ID	Title	ApplNo	IPC	Applicant	Subgroup	زیر گروه	رشته	شرح	Description
2025	47	WO/2025/104491	INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO	IB2024/000644	C07D 403/06	MINDSET PHARMA INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/137564	COELENTERAZINE ANALOGUES FOR THE DETECTION OF LUMINESCENCE IN LUCIFERASE-BASED ASSAYS	US2024/061450	C07D 487/04	PROMEGA CORPORATION	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/186433	PROCESS AND INTERMEDIATES FOR THE PRODUCTION OF A JAK1 INHIBITOR	EP2025/056257	C07D 403/04	ASTRAZENECA AB	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/199170	POLYMORPHIC FORMS OF KRAS INHIBITORS AND USES THEREOF	US2025/020472	C07D 471/04	FRONTIER MEDICINES CORPORATION	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/215527	COMBINATION THERAPY FOR THE TREATMENT OF CANCER COMPRISING A WRN INHIBITOR, RADIATION THERAPY, CARBOPLATIN AND PACLITAXEL	IB2025/053691	C07D 487/14	NOVARTIS AG	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/217347	PROCESS OF PREPARING REPOTRECTINIB	US2025/023989	C07D 498/18	BRISTOL-MYERS SQUIBB COMPANY	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/236095	MODULATORS OF ALPHA-1 ANTITRYPSIN	CA2025/050702	C07D 487/04	CONGRUENCE THERAPEUTICS INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/236100	SUBSTITUTED HETEROCYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF	CA2025/050711	C07D 519/00	UNIVERSITÉ DE MONTRÉAL	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/236325	NATURAL BLUE PIGMENT AND BIOSYNTHESIS METHOD THEREFOR	CN2024/095947	C07D 213/75	VERTEXYN BIOWORKS CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/236508	METHOD FOR SYNTHESIZING CHIRAL 3-HYDROXY-4-FLUOROPIPERIDINE DERIVATIVE, AND METHOD FOR RESOLVING CHIRAL 3-HYDROXY-4-FLUOROPIPERIDINE DERIVATIVE	CN2024/119467	C07D 211/42	CHENGDA PHARMACEUTICALS CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/236565	HETEROCYCLOALKYL CARBOXYLIC ACID DERIVATIVE, INTERMEDIATE, PREPARATION METHOD THEREFOR AND USE THEREOF	CN2024/130463	C07D 209/92	LANCETOME (BEIJING) BIOTECH LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/236836	N-(3-FLUOROBENZYL)-1H-INDAZOLE-5-AMINE DERIVATIVE AND USE THEREOF	CN2025/082479	C07D 261/20	SHENYANG PHARMACEUTICAL UNIVERSITY	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/236847	PYRROLO[3,2-B]PYRIDINE TOPOISOMERASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	CN2025/083340	C07D 471/04	NANJING HONGSHUN PHARMACEUTICAL TECHNOLOGY CO., LTD	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/236852	SEH INHIBITOR COMPOUND, PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF	CN2025/083855	C07D 215/38	BEIJING INSTITUTE OF TECHNOLOGY	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/236860	BUFOTENINE DERIVATIVE AND USE THEREOF IN ANALGESIC AND ANTIDEPRESSANT DRUGS	CN2025/084514	C07D 209/16	NANJING XIAOZHEN BIOTECHNOLOGY CO., LTD	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237083	ORGANIC COMPOUND, ELECTROLUMINESCENT DEVICE, AND DISPLAY APPARATUS	CN2025/092203	C07D 519/00	BOE TECHNOLOGY GROUP CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237091	PREPARATION METHOD FOR SPIRO COMPOUND, AND INTERMEDIATE THEREOF	CN2025/092529	C07D 471/10	EUREGEN BIOPHARMA CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237171	PYRIMIDINE-FUSED FIVE-MEMBERED AZACYCLIC PHENOL COMPOUND AND USE THEREOF	CN2025/093658	C07D 487/04	GUANGZHOU UNIRISE PHARMACEUTICAL CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237188	LP(A) INHIBITOR COMPOUND AND USE THEREOF	CN2025/093771	C07D 207/08	SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237193	MIXTURE, COMPOSITION, ORGANIC COMPOUND CONSTITUTING SAME, AND USE THEREOF IN ORGANIC ELECTRONIC DEVICE	CN2025/093811	C07D 495/04	ZHEJIANG BRILLIANT OPTOELECTRONIC TECHNOLOGY CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237199	NITROGEN-CONTAINING FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF	CN2025/093896	C07D 471/04	SHANGHAI QILU PHARMACEUTICAL RESEARCH AND DEVELOPMENT CENTRE LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237211	CRYSTAL FORM OF CYP11A1 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF	CN2025/094043	C07D 405/06	LIAONING HAISCO PHARMACEUTICAL CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237212	PYRIMIDINE DERIVATIVE MEGLUMINE SALT AND CRYSTAL FORMS THEREOF	CN2025/094126	C07D 471/04	GUANGDONG RAYNOVENT BIOTECH CO., LTD	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237216	TSHR ANTAGONIST COMPOUND, PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF	CN2025/094173	C07D 215/38	CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237237	COMPLEMENT FACTOR B INHIBITORS	CN2025/094269	C07D 495/10	ALEBUND PHARMACEUTICALS (HONG KONG) LIMITED	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237242	SMARCA2 INHIBITOR AND USES THEREOF	CN2025/094302	C07D 471/04	ABBISKO THERAPEUTICS CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237255	COMPOUND AS XANTHINE OXIDASE INHIBITOR AND USE THEREOF	CN2025/094425	C07D 471/04	GUANGZHOU UNIRISE PHARMACEUTICAL CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237258	CDK INHIBITOR COMPOUND WITH LACTAM STRUCTURE	CN2025/094439	C07D 413/14	ADLAI NORTYE PTE. LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237291	PREPARATION METHOD FOR ISOPROPYLISOQUINOLINE COMPOUND AND INTERMEDIATE THEREOF	CN2025/094584	C07D 217/24	SHANGHAI HANSOH BIOMEDICAL CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237303	β-GLUCOCEREBROSIDASE ALLOSTERIC MODULATOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF	CN2025/094632	C07D 487/04	SIMCERE PHARMACEUTICAL CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237304	AMIDE COMPOUND FOR TREATING AND/OR PREVENTING HEPATITIS VIRUS INFECTIONS	CN2025/094633	C07D 207/34	SHANGHAI ZHIMENG BIOPHARMA, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237312	HIGH-SELECTIVITY FGFR2 INHIBITOR CONTAINING BENZISOXAZOLE STRUCTURE AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF	CN2025/094724	C07D 261/20	SHENZHEN FORWARD PHARMACEUTICALS CO., LIMITED	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237318	BENZO NITROGEN-CONTAINING HETEROCYCLIC STING INHIBITOR AND MEDICAL USE THEREOF	CN2025/094780	C07D 401/12	CHINA PHARMACEUTICAL UNIVERSITY	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237322	PYRAZOLE STING INHIBITOR AND PHARMACEUTICAL USE THEREOF	CN2025/094797	C07D 401/12	CHINA PHARMACEUTICAL UNIVERSITY	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237323	THIAZOLE-BASED STING INHIBITOR AND PHARMACEUTICAL USE THEREOF	CN2025/094801	C07D 495/04	CHINA PHARMACEUTICAL UNIVERSITY	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237335	PHARMACEUTICALLY ACCEPTABLE SALT OF CUCURBITURIL DERIVATIVE, CRYSTAL FORM THEREOF AND USE THEREOF	CN2025/094868	C07D 487/22	JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237337	THIAZOLE SUBSTITUTED PYRIMIDINAMINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF	CN2025/094883	C07D 417/14	ZHEJIANG YANGLI PHARMACEUTICAL TECHNOLOGY CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237356	COMPOUNDS, COMPOSITIONS AND METHODS THEREOF	CN2025/095004	C07D 401/14	HEPAITECH (BEIJING) BIOPHARMA TECHNOLOGY CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237361	OXO-TRICYCLIC DERIVATIVE AND USE THEREOF IN MEDICINE	CN2025/095038	C07D 471/14	HAISCO PHARMACEUTICAL GROUP CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237374	PI3Kα INHIBITOR, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF	CN2025/095135	C07D 498/04	WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237389	TRICYCLIC WRN INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF	CN2025/095279	C07D 487/14	CHENGDU CHIPSCREEN PHARMACEUTICAL LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237391	CRYSTAL FORMS OF SSTR4 AGONIST COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF	CN2025/095290	C07D 471/04	GUANGZHOU FERMION TECHNOLOGY CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237398	FIVE-MEMBERED HETEROAROMATIC RING DERIVATIVE AND USE THEREOF	CN2025/095344	C07D 277/56	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237402	YOHIMBINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	CN2025/095380	C07D 459/00	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237404	POLYMORPH OF MC4R ANTAGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF	CN2025/095404	C07D 401/14	CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237405	COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF	CN2025/095415	C07D 401/14	CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237418	SALT AND CRYSTAL FORM OF CDK2 INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF	CN2025/095535	C07D 401/12	SHANDONG LUYE PHARMACEUTICAL CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237421	NEW CONJUGATE MOLECULE AS ANDROGEN RECEPTOR MODULATOR AND USE THEREOF	CN2025/095651	C07D 471/10	QINGDAO PROCIVA THERAPEUTICS CO., LTD	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237437	PREPARATION METHOD FOR GLP-1 RECEPTOR AGONIST INTERMEDIATE AND USE THEREOF	CN2025/101660	C07D 405/00	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237860	HERBICIDAL 4-HYDROXY-HEXAHYDROFURO[3,4-B]FURAN DERIVATIVES	EP2025/062823	C07D 493/04	BAYER AKTIENGESELLSCHAFT	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/237891	QUINOLINE-2-CARBOXAMIDE DERIVATIVES AS RAD51 INHIBITORS FOR THE TREATMENT OF CANCER	EP2025/062878	C07D 401/12	NERVIANO MEDICAL SCIENCES S.R.L.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/238054	ANILINE-BASED MODULATORS OF THE NUCLEAR RECEPTOR TLX (NR2E1)	EP2025/063165	C07D 209/18	LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN, IN VERTRETUNG DES FREISTAATES BAYERN	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/238416	INDOLE DERIVATIVES, USES AND COMPOSITIONS THEREOF	IB2025/000216	C07D 209/16	MINDSET PHARMA INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/238545	CREATINE KINASE INHIBITORS	IB2025/055006	C07D 209/20	DANA-FARBER CANCER INSTITUTE, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/238550	CREATINE KINASE INHIBITORS	IB2025/055013	C07D 417/12	DANA-FARBER CANCER INSTITUTE, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/238559	METHOD OF MAKING UDENAFIL AND INTERMEDIATES THEREOF	IB2025/055022	C07D 487/04	MEZZION PHARMA CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/238595	PROCESS FOR PREPARING (R)-2-AMINO-3-(7-METHYL-1H-INDAZOL-5-YL) METHYL PROPANOATE, AND USE THEREOF AS INTERMEDIATE FOR THE SYNTHESIS OF ZAVEGEPANT	IB2025/055089	C07D 231/56	OLON S.P.A.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/238661	AN IMPROVED PROCESS FOR THE PREPARATION OF OSIMERTINIB	IN2025/050758	C07D 403/04	BDR LIFESCIENCES PRIVATE LIMITED	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/238662	IMPROVED PROCESS FOR THE PREPARATION OF 4-AMINO-N-[(1S)-1-(4-CHLOROPHENYL)-3-HYDROXYPROPYL]-1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-4-PIPERIDINECARBOXAMIDE AND ITS SALTS	IN2025/050759	C07D 7/04	MSN LABORATORIES PRIVATE LIMITED, R&D CENTER	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/239079	ALICYCLIC DIAMINE AND ALICYCLIC-DIAMINE COMPOSITION	JP2025/014480	C07D 493/18	MITSUBISHI GAS CHEMICAL COMPANY, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/239339	OXIRANE AMIDE COMPOUND OR SALT THEREOF, AGRICULTURAL/HORTICULTURAL FUNGICIDE CONTAINING COMPOUND THEREOF, AND METHOD FOR USING SAID AGRICULTURAL/HORTICULTURAL FUNGICIDE	JP2025/017300	C07D 405/12	NIHON NOHYAKU CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/239340	AMIDE COMPOUND OR SALT THEREOF, AGRICULTURAL AND HORTICULTURAL MICROBICIDE CONTAINING SAID COMPOUND OR SALT, AND METHOD FOR USING SAID MICROBICIDE	JP2025/017301	C07D 213/40	NIHON NOHYAKU CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/239453	FUNCTIONAL COMPOUND	JP2025/017919	C07D 495/04	OTSUKA PHARMACEUTICAL CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/239502	DUAL FLUORESCENCE PROBE FOR DETECTING NITROREDUCTASE AND HYDROGEN SULFIDE, AND MANUFACTURING METHOD THEREFOR	KR2025/001521	C07D 413/14	CHUNG ANG UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/239662	PLK1 DEGRADATION-INDUCING COMPOUNDS FOR DEGRADER-ANTIBODY CONJUGATE	KR2025/006502	C07D 475/00	UPPTHERA, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/239667	HETEROCYCLIC COMPOUND AS LRRK2 INHIBITOR	KR2025/006517	C07D 471/04	IMMUSE THERAPEUTICS, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/239794	ATAXIA TELANGIECTASIA AND RAD3-RELATED INHIBITORS	RU2025/050136	C07D 471/04	JOINT STOCK COMPANY “BIOCAD”	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/239965	INHIBITORS OF CDC14 PHOSPHATASES AND RELATED COMPOSITIONS AND METHODS OF USE	US2025/017351	C07D 307/78	PURDUE RESEARCH FOUNDATION	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240238	THIENO[3,4-D]PYRIMIDIN-4-AMINE INHIBITORS OF HCK	US2025/028559	C07D 495/04	DANA-FARBER CANCER INSTITUTE, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240240	NOVEL SPIROCYCLE DERIVATIVES AS INHIBITORS OF HCK	US2025/028562	C07D 487/04	DANA-FARBER CANCER INSTITUTE, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240247	HETEROCYCLIC COMPOUNDS AS NRF2 INHIBITORS	US2025/028577	C07D 413/12	SYNNOVATION THERAPEUTICS, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240390	MARY1 AND DERIVATIVES THEREOF FOR THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION, VASCULAR INJURY, KIDNEY DISEASES, AND ORGAN AGING	US2025/029024	C07D 401/06	ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240456	NOVEL AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF	US2025/029114	C07D 207/09	SAMSARA THERAPEUTICS INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240465	PROCESSES FOR PREPARING MACROCYCLIC COMPOUNDS	US2025/029124	C07D 487/04	AMGEN INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240512	NOVEL IBOGA ALKALOID ANALOGS AND THEIR USES THEREOF	US2025/029188	C07D 495/22	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240517	CDK4 INHIBITOR NAPHTHYRIDINE COMPOUNDS	US2025/029199	C07D 471/04	ALEKSIA THERAPEUTICS, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240531	AMINO PYRIMIDINE DEGRADERS AND USES THEREOF	US2025/029218	C07D 401/14	ALEKSIA THERAPEUTICS, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240582	MACROCYCLIC COMPOUNDS AS MODULATORS OF KRAS AND USES THEREOF	US2025/029306	C07D 519/00	AMGEN INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240706	CRYSTALLINE FORMS OF KRAS G12D INHIBITOR AND USES THEREOF	US2025/029508	C07D 471/04	RANOK THERAPEUTICS (HANGZHOU) CO. LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240740	SMALL MOLECULE PROTEIN DEGRADERS OF KRAS G12D MUTANT	US2025/029557	C07D 519/00	MERCK SHARP & DOHME LLC	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240742	PROTEIN DEGRADERS OF KRAS G12D MUTANT	US2025/029560	C07D 471/14	MERCK SHARP & DOHME LLC	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240808	CRYSTALLINE FORMS OF OXATHIAZOLIDINE UREA COMPOUNDS HAVING PESTICIDAL ACTIVITY	US2025/029672	C07D 417/12	CORTEVA AGRISCIENCE LLC	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240809	PROCESSES RELATED TO PREPARATION OF TRIAZOLE OXATHIAZOLIDINE DERIVATIVES	US2025/029673	C07D 417/12	CORTEVA AGRISCIENCE LLC	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240818	AGONISTS OF 8-OXO-GUANINE DNA GLYCOSYLASE	US2025/029690	C07D 233/64	OREGON HEALTH & SCIENCE UNIVERSITY	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240823	PROCESSES RELATED TO PREPARATION OF TRIAZOLE DERIVATIVES	US2025/029697	C07D 249/08	CORTEVA AGRISCIENCE LLC	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240834	NSD2-TARGETED CHEMICAL DEGRADERS AND COMPOSITIONS AND METHODS OF USE THEREOF	US2025/029715	C07D 265/36	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240835	JAK2 INHIBITORS AND THEIR USE AS PHARMACEUTICALS	US2025/029716	C07D 201/00	PRELUDE THERAPEUTICS INCORPORATED	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240840	AROMATIC HETEROCYCLE DERIVATIVES AND AROMATIC CARBOCYCLE DERIVATIVES HAVING PDE4D INHIBITORY ACTIVITY	US2025/029730	C07D 213/30	SHIONOGI & CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240847	RAS INHIBITORS	US2025/029742	C07D 401/14	REVOLUTION MEDICINES, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240868	METHOD OF USING CHEMICALLY STABLE KETO-AMIDE FIBROBLAST ACTIVATION PROTEIN-TARGETED CONJUGATES AND COMPOSITIONS COMPRISING SAME TO TREAT FIBROSIS	US2025/029775	C07D 207/12	PURDUE RESEARCH FOUNDATION	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240893	4-PHENYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXAMIDE DERIVATIVES AS AMYLIN AND/OR CALCITONIN RECEPTOR AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES, OBESITY OR OVERWEIGHT	US2025/029816	C07D 471/04	ELI LILLY AND COMPANY	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240895	SUBSTITUTED CYCLOALKYL AND HETEROCYCLOALKYL INHIBITORS OF NAv1.8 FOR THE TREATMENT OF PAIN	US2025/029820	C07D 213/75	SITEONE THERAPEUTICS, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	47	WO/2025/240977	COMPOSITIONS OF SULFONYL-PURINE COMPOUNDS AND USE THEREOF FOR MODIFYING FUNCTIONAL PROTEIN SITES	US2025/030073	C07D 473/00	BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی